GlassScriptPhysician profile
John K Miller
NPI 1063642205
$11,622.38
in general payments reported to CMS, 2019-2025
19 companies · $61.05 in 2025
The $61.05 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $237 · 2021: $151 · 2022: $10K · 2023: $309 · 2024: $368 · 2025: $61.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,356.92 | 2019-2023 | |
| Ethicon US, LLC | $309.51 | 2019-2021 | |
| Convatec INC. | $251.83 | 2023-2024 | |
| Organogenesis INC. | $185.79 | 2021-2024 | Novachor |
| Davol INC. | $111.89 | 2019-2020 | |
| Mimedx Group, INC. | $93.69 | 2024-2025 | |
| Polymedics Innovations INC. | $36.27 | 2024 | |
| Currax Pharmaceuticals LLC | $33.61 | 2022-2023 | Contrave |
| Astrazeneca Pharmaceuticals LP | $32.78 | 2023-2024 | Farxiga |
| Integra Lifesciences Corporation | $29.44 | 2023 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Kci USA, INC. | $26.49 | 2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Smith+Nephew, INC. | $23.07 | 2019 | |
| Reprise Biomedical, INC. | $22.66 | 2024 | Miro3d |
| Novo Nordisk INC | $21.76 | 2023 | Wegovy, Saxenda |
| Bone Support INC. | $20.53 | 2024 | Cerament G, Ceramentbone Void Filler |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $19.15 | 2023 | |
| Atricure, INC. | $16.48 | 2023 | |
| Paratek Pharmaceuticals, INC. | $16.03 | 2025 | Nuzyra |
| Pacira Pharmaceuticals Incorporated | $14.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.